Medical treatment of retinal vein occlusions

Seminars in Ophthalmology

Volumn 19, Issue 1-2, 2004, Pages 43-48

  Parodi, Maurizio Battaglia ^a,b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

Author keywords

Corticosteroid; Hemodilution; Retinal Vein Occlusion; Troxerutin

Indexed keywords

ANTICOAGULANT AGENT; CARBONATE DEHYDRATASE INHIBITOR; CORTICOSTEROID; FIBRINOLYTIC AGENT; PENTOXIFYLLINE; PROTEIN KINASE C INHIBITOR; STEROID; TROXERUTIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; HEMODILUTION; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA VEIN OCCLUSION; RISK FACTOR;

ANTICOAGULANTS; CLINICAL TRIALS; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; GLUCOCORTICOIDS; HEMODILUTION; HUMANS; RETINAL VEIN OCCLUSION; TREATMENT OUTCOME;

EID: 10644278858     PISSN: 08820538     EISSN: None     Source Type: Journal    
DOI: 10.1080/08820530490520040     Document Type: Article

References (34)

1. Hayreh SS, Zimmerman MB, Podhajsky P. Hematologic abnormalities associated with various types of retinal vein occlusion. Graefe's Arch Clin Exp Ophthalmol. 2002;240:180-196.
2. Hayreh SS. Management of central retinal vein occlusion. Ophthalmologica. 2003;217:167-188.
3. Durand F, Delamaire M, Carre V et al. Study of hemorheologic parameters in patients with retinal vein occlusion. Clin Haemorheol. 1991;11:533-536.
4. Hansen LL, Wiek J, Wiederholt M. A randomized prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution. Br J Ophthalmol. 1898;73:895-898.
5. Kohner EM, Laatikainen L, Oughton J. The management of central retinal vein occlusion. Ophthalmology. 1983;90:484-487.
6. Finkelstein D. Retinal branch vein occlusion. In Ryan SJ: Retina Vol 2. St Luouis, CV Mosby. 1989;427-432.
7. Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM. A randomized, double-masked study on the treatment of retinal vein occlusion with troxuretin. Am J Ophthalmol. 1994;118:421-429.
8. Browning DJ, Fraser CM. Retinal vein occlusion in patients taking warfarin. Ophthalmology. 2004;111:1196-1200.
9. Wadworth AN, Faulds D. Hydroxyethylrutosides. A review of its pharmacology and therapeutic efficacy in venous insufficiency and related disorders. Drugs. 1992;44:1013-1016.
10. Hayreh SS. Central retinal vein occlusion. In: Mausolf FA. Th Eye and Systemic Disease. Ed 2. St Louis. CV Mosby. 1980;223-275.
11. Fong AC, Schatz H. Central retinal vein occlusion in young adults. Surv Ophthalmol. 1993;37:393-417.
12. Shaikh S, Blumenkranz MS. Transient improvement in visual acuity and macular edema in central retinal vein occlusion accompanied by inflammatory features after pulse steroid and anti-inflammatory therapy. Retina. 2001;21:176-177.
13. Kohner EM, Hamilton AM, Bulpitt CJ, Dollery CT. Streptokinase in the treatment of central retinal vein occlusion: A controlled trial. Trans Ophthalmol Soc UK. 1974;94:599-603.
14. Elman MJ. Thrombolytic therapy for central retinal vein occlusion: Results of a pilot study. Trans Am Ophthalmol Soc. 1996;94:471-504.
15. Williamson TH, Baxter GM. Central retinal vein occlusion: An investigation by color doppler imaging: Blood velocities characteristics and prediction of iris neovascularisation. Ophthalmology. 1994;84:581-586.
16. Arsene S, Giraudeau B, Le Lez ML et al. Follow up by colour Doppler imaging of 102 patients with retinal vein occlusion over 1 year. Br J Ophthalmol. 2002;86:1243-1247.
17. Ozbek Z, Saatci AO, Durak I et al. Colour Doppler assessment of blood flow in eyes with central retinal vein occlusion. Ophthalmologica. 2002;216:231-234.
18. McGrath MA, Wechsler F, Hunyor AB, Penny R. Systemic factors contributory to retinal vein occlusion. Arch Intern Med. 1978;138:216-220.
19. Peduzzi M, Debbia A, Guerrieri F, Bolzani R. Abnormal blood rheology in retinal vein occlusion. A preliminary report. Graefes Arch Clin Exp Ophthalmol. 1986;224:83-85.
20. Ring CP, Pearson TC, Sanders MD, Wetherley-Mein G. Viscosity and retinal vein thrombosis. Br J Ophthalmol. 1976;60:397-410.
21. Piermarocchi S, Segato T, Bertoja H et al. Branch retinal vein occlusion: the pathogenetic role of blood viscosity. Ann Ophthalmol. 1990;22:303-311.
22. Lip PL, Blann AD, Jones AF, Lip GY. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk. Eye. 1998;12:245-251.
23. Wiederholt M, Leonhardt H, Schmid-Schonbein H, Hager H. Treatment of central retinal venous and arterial occlusion by isovolemic hemodilution. Klin Monatsbl Augenheilkd. 1980;177:157-164.
24. Hansen LL, Danisevskis P, Arntz HR et al. A randomised prospective study on treatment of central retinal vein occlusion by isovolaemic haemodilution and photocoagulation. Br J Ophthalmol. 1985;69:108-116.
25. Hansen LL, Wiek J, Schade M et al. Effect and compatibility of isovolaemic haemodilution in the treatment of ischaemic and non-ischaemic central retinal vein occlusion. Ophthalmologica. 1989;199:90-99.
26. Hansen LL, Wiek J, Wiederholt M. A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution. Br J Ophthalmol. 1989;73:895-899.
27. Wolf S, Arend O, Bertram B et al. Hemodilution in patients with central retinal vein thrombosis. A placebo-controlled randomized study. Fortschr Ophthalmol. 1991;88:35-43.
28. Schumann M, Hansen LL, Janknecht P, Witschel H. Isovolemic hemodilution in central retinal vein occlusion in patients less than 50 years of age. Klin Monatsbl Augenheilkd. 1993;203:341-346.
29. Wolf S, Arend O, Bertram B et al. Hemodilution therapy in central retinal vein occlusion. One-year results of a prospective randomized study. Graefes Arch Clin Exp Ophthalmol. 1994;232:33-39.
30. Luckie AP, Wroblewski JJ, Hamilton P et al. A randomised prospective study of outpatient haemodilution for central retinal vein obstruction. Aust N Z J Ophthalmol. 1996;24:223-232.
31. Chen HC, Wiek J, Gupta A et al. Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion. Br J Ophthalmol. 1998;82:162-7.
32. Hattenbach LO, Wellermann G, Steinkamp GW et al. Visual outcome after treatment with low-dose recombinant tissue plasminogen activator or hemodilution in ischemic central retinal vein occlusion. Ophthalmologica. 1999;213:360-366.
33. Glacet-Bernard A, Zourdani A, Milhoub M et al. Effect of isovolemic hemodilution in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2001;239:909-914.
34. Neely KA, Ernest JT, Goldstick TK et al. Isovolemic hemodilution increases retinal tissue oxygen tension. Graefe's Arch Clin Exp Ophthalmol. 1996;234:688-694.